GSK plc GSK announced that it has signed an agreement with Massachusetts-based biopharmaceutical company Boston ...

Roche is among several drugmakers to announce large-scale U.S. investments in response to Trump's push to onshore ...

Polanco, executive VP and chief commercial officer, Novartis US, and the 2025 Healthcare Businesswomen’s Association Woman of ...

U.S. President Donald Trump's executive order on drug pricing threatens Roche's planned $50 billion investment in the United ...

Roche Holding AG said it would need to reconsider planned US investments if President Donald Trump implements an executive ...

Greek use of interoperable digital tools and secure data platforms such as the EHDS could boost early detection and ...

THE Court of Tax Appeals (CTA) has granted a P31.75 million tax refund claim filed by a local importer of maintenance medicines for erroneously paid taxes in 2020. In a 19-page decision of the CTA’s ...

Swiss pharma firm Roche could reconsider investing billions of dollars in the US after Trump medication prices..

"We are very pleased to expand our IgA nephropathy campaign with new resources to help patients better understand this rare kidney disease,” said LaVarne A. Burton, AKF President and CEO. "With ...

Incyte said it agreed to pay Novartis $280 million to settle the disputed royalties on U.S. sales of blood-cancer treatment Jakafi through Dec. 31. The parties also agreed to reduce by 50% the royalty ...

Greek use of interoperable digital tools and secure data platforms such as the EHDS could boost early detection and personalised treatment, while advancing CVD care, a senior Novartis executive tells ...

Revisions to classification criteria ‘will ensure homogeneous trial populations’ with data-driven scoring, a standardized MRI ...